Bortezomib - Induced Paralytic Ileus: Uncommon but Crucial
Bortezomib is a targeted anti - cancer medication used primarily to treat Multiple Myeloma and Mantle Cell Lymphoma in adults. It is classified as a Protease Inhibitor, which works by reversibly inhibiting the protein complex responsible for degrading damaged proteins within cells.[1] We report the case of a patient with Multiple Myeloma who developed Paralytic Ileus while on Bortezomib.
Authors
- Rimal Roy
- Sara Kodiattu
- Rency Abraham
- R S Jacob
Publication Details
- Journal
- International Journal For Multidisciplinary Research
- Published
- 2025-08-10
- DOI
- https://doi.org/10.36948/ijfmr.2025.v07i04.53056
- Primary Topic
- Gastrointestinal Tumor Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00